CVS just announced a super cheap generic alternative to EpiPen

https://cdn.arstechnica.net/wp-content/uploads/2017/01/GettyImages-597987772-800x534.jpg

Pharmaceutical giant CVS announced Thursday that it has partnered with Impax Laboratories to sell a generic epinephrine auto-injector for $109.99 for a two-pack—a dramatic cut from Mylan’s Epipen two-pack prices, which list for more than $600 as a brand name and $300 as a generic.

The lower-cost auto-injector, a generic form of Adrenaclick, is available starting today nationwide in the company’s more than 9,600 pharmacies. Its price resembles that of EpiPen’s before Mylan bought the rights to the life-saving devices back in 2007 and raised the price repeatedly, sparking outcry.

Tags: 

Read more: CVS just announced a super cheap generic alternative to EpiPen

Story added 13. January 2017, content source with full text you can find at link above.